[Fructosamine determination as a screening test for diabetes mellitus in patients with acute coronary heart disease].
Plasma fructosamine was determined in 41 patients with acute coronary heart disease (acute myocardial infarction and instable angina) to assess its usefulness as a screening method for diabetes mellitus. The results (11/15 true positive and 23/26 true negative) were comparable to those for glycated hemoglobin (14/15, 22/26). Discriminant analysis was performed to extract additional information from further laboratory data (glucose and albumin).
Thurnheer
U
U
Medizinische Abteilung, Anna-Seiler-Haus, Inselspital, Bern.
Hess
T
T
Degiampietro
P
P
Peheim
E
E
D003327:Coronary Disease / Q000097:blood* / Q000150:complications; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000150:complications; D019270:Fructosamine; D005951:Glucose Tolerance Test; D006442:Glycated Hemoglobin / Q000032:analysis; D006595:Hexosamines / Q000097:blood*; D006801:Humans; D009203:Myocardial Infarction / Q000097:blood
D019270:Fructosamine; D006442:Glycated Hemoglobin; D006595:Hexosamines
Die Fructosaminbestimmung als Screeninguntersuchung für Diabetes mellitus bei Patienten mit akuter koronarer Herzkrankheit.